October 23, 2025Cancer MedicineOpen Access

Clinical Features and Outcomes of Primary Colorectal Diffuse Large B‐Cell Lymphoma: A Multicenter Retrospective Study

View Full Paper

Ask AI

Bookmark

Progression-free survival at 72.3% indicates effective R-CHOP treatment for colorectal DLBCL patients.
Majority of colorectal cases presented with limited-stage disease and obstructive symptoms leading to diagnosis.
Retrospective collection of 104 cases from three institutions highlights varied treatment outcomes by disease origin.
Improved local disease control observed with primary tumor resection; however, this did not translate to overall survival benefits.

Discussion

No takes yet. Share an insight, caveat, or question.

Retrospective analysis shows 80% complete remission in colorectal DLBCL, suggesting effective R-CHOP treatment outcomes and relapse rates.

Lee et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective analysis shows 80% complete remission in colorectal DLBCL, suggesting effective R-CHOP treatment outcomes and relapse rates.